These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29276353)

  • 1. A Cross-Sectional Study on the Characteristics of Tardive Dyskinesia in Patients with Chronic Schizophrenia.
    Huang Y; Pan L; Teng F; Wang G; Li C; Jin L
    Shanghai Arch Psychiatry; 2017 Oct; 29(5):295-303. PubMed ID: 29276353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
    Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
    Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia.
    Uludag K; Wang DM; Goodman C; Chen DC; Wang L; Zhang X
    Asian J Psychiatr; 2021 Dec; 66():102877. PubMed ID: 34638091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
    Caroff SN; Davis VG; Miller DD; Davis SM; Rosenheck RA; McEvoy JP; Campbell EC; Saltz BL; Riggio S; Chakos MH; Swartz MS; Keefe RS; Stroup TS; Lieberman JA;
    J Clin Psychiatry; 2011 Mar; 72(3):295-303. PubMed ID: 20816031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
    Apud JA; Egan MF; Wyatt RJ
    Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and tardive dyskinesia in male patients with chronic schizophrenia.
    Zhang XY; Yu YQ; Sun S; Zhang X; Li W; Xiu MH; Chen DC; Yang FD; Zhu F; Kosten TA; Kosten TR
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1765-9. PubMed ID: 21723906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study.
    Bai YM; Chou KH; Lin CP; Chen IY; Li CT; Yang KC; Chou YH; Su TP
    Schizophr Res; 2009 Apr; 109(1-3):167-81. PubMed ID: 19261444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
    Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
    Kane JM; Correll CU; Liang GS; Burke J; O'Brien CF
    Psychopharmacol Bull; 2017 Aug; 47(3):69-76. PubMed ID: 28839342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter abnormalities in schizophrenia patients with tardive dyskinesia: a magnetic resonance imaging voxel-based morphometry study.
    Li CT; Chou KH; Su TP; Huang CC; Chen MH; Bai YM; Lin CP
    PLoS One; 2013; 8(8):e71034. PubMed ID: 23967150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement.
    Yu T; Li Y; Fan F; Cao H; Luo X; Tan S; Yang F; Zhang X; Shugart YY; Hong LE; Li CR; Tan Y
    Sci Rep; 2018 Aug; 8(1):12884. PubMed ID: 30150749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
    Correll CU; Josiassen RC; Liang GS; Burke J; O'Brien CF
    Psychopharmacol Bull; 2017 Aug; 47(3):53-60. PubMed ID: 28839340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia.
    Rekhi G; Tay J; Lee J
    J Psychopharmacol; 2022 Feb; 36(2):183-190. PubMed ID: 34979813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
    Caroff SN; Leong SH; Roberts CB; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(4):373-380. PubMed ID: 32639290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
    Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia.
    Lyu X; Li Z; Chen S; Gu S; Zhou Z; Yang R; Yang P; Zhang G; Li C; Yuan N; Yin M; Zhang W; Wei X; Huang X; Du X
    Clin Neurophysiol; 2024 Oct; 166():20-30. PubMed ID: 39084156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
    Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
    Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
    Farber RH; Stull DE; Witherspoon B; Evans CJ; Yonan C; Bron M; Dhanda R; Jen E; Brien CO'
    J Patient Rep Outcomes; 2024 Jan; 8(1):2. PubMed ID: 38175450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.